Celyad Oncology SA (EBR:CYAD)

Celyad Oncology Revenue

In the year 2025, Celyad Oncology had annual revenue of 21.00K EUR, down -88.71%. Celyad Oncology had revenue of 7.00K in the half year ending December 31, 2025, a decrease of -87.93%.

• Revenue: 21.00K
• Revenue Growth: -88.71%
• P/S Ratio: 618.14
• Revenue / Employee: 4.20K
• Employees: 5
• Market Cap: 12.98M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	21.00K	-165.00K	-88.71%
Dec 31, 2024	186.00K	84.00K	82.35%
Dec 31, 2023	102.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 20, 2026

Data Sources Report a data error